BioMarin Pharmaceutical

BMRN · NASDAQ · Healthcare

$63.81

+$2.44 (+3.82%) today

Loading live data...

Market Cap

$12.33B

24h Volume

$278.5M

P/E Ratio

172.5

52w High

$64.08

52w Low

$49.67

Est. AI Revenue

12%

Loading chart data...

7-Day Sparkline (Static)

About BioMarin Pharmaceutical

Rare disease biotech using AI for gene therapy optimization, patient identification algorithms, and computational protein engineering for enzyme replacement.

CEO: Alexander Hardy

Founded: 1997

HQ: San Rafael, California

Employees: 3,221

Performance

24 Hours+3.82%

7 Days+6.31%

30 Days+6.40%

1 Year+11.30%